Last updated on October 2018

Safety and Efficacy of EMA401 in Patients With Painful Diabetic Neuropathy (PDN)


Brief description of study

The purpose of this study is to evaluate safety and efficacy of EMA401 compared to placebo in patients with painful diabetic neuropathy (PDN).

Clinical Study Identifier: NCT03297294

Contact Investigators or Research Sites near you

Start Over

Novartis Pharmaceuticals

Novartis Investigative Site
Lubbeek, Belgium
7.8miles
  Connect »